Windy Dean-Colomb, MD
Fax: (833) 605-3536
Business hours
| Monday | 8:00am to 5:00pm |
| Tuesday | 8:00am to 5:00pm |
| Wednesday | 8:00am to 5:00pm |
| Thursday | 8:00am to 5:00pm |
| Friday | 8:00am to 5:00pm |
| Saturday | - |
| Sunday | - |
About us
Windy Dean-Colomb, M.D., PhD., earned her medical degree and completed her residency from the University of Illinois College of Medicine. She then completed her fellowship in Medical Oncology at MD Anderson Cancer Center in Houston. She is board certified in Medical Oncology and Internal Medicine. Dr. Dean-Colomb has been practicing medicine for over 16 years. Prior to joining Piedmont, she was a medical oncologist at JD Moncus Cancer Center in Lafayette, LA. She specializes in breast and prostate cancer and her special interests include eliminating cancer disparity by increasing access to care for people from all walks of life and promoting personalized medicine through increased genomic testing. She treats all solid tumors and non-acute hematologic malignancies. In her spare time, she enjoys reading, bowling, spending time with family and participating in medical missions around the globe. Dr. Dean-Colomb is accepting new patients and welcomes most major insurance plans.
Schedule an Appointment Today!
| Languages | English |
| Tags | abdominal cancer, abdominal cancer chemotherapy, adenocarcinoma of the bladder, adjuvant chemotherapy, adolescent and young adult cancer (aya), advanced malignancies, anal cancer chemotherapy, anaplastic cancer of thyroid, androgen deprivation therapy, anorectal cancer chemotherapy, appendiceal cancer chemotherapy, autoimmune cytopenia, biliary tract cancer chemotherapy, brain metastases, breast cancer chemotherapy, cancer, cancer chemotherapy, cancer during pregnancy, cancer genomics, cancer immunotherapy, cancer of the joints, cancer of the muscles, cancer pain, cancer related fatigue, cancer risk, cancer survivor, carcinoma of unknown primary, cervical and endometrial cancers, cervical cancer, cervical cancer chemotherapy, chemoradiation, cholangiocarcinoma, clinical trials, colon cancer chemotherapy, colon cancer genomics, colorectal cancer chemotherapy, colorectal malignancy, cowden syndrome, diaphragm cancer, egfr mutation, egfr translocation, electrolyte abnormalities in cancer patients, endometrial cancer chemotherapy, esophageal cancer, esophageal cancer chemotherapy, eye cancer, eye cancer chemotherapy, eyelid cancer, eyelid cancer chemotherapy, face cancer, familial renal cell carcinoma, fibrolamellar carcinoma, gallbladder cancer, gallbladder cancer chemotherapy, gallbladder cancer genomics, gastroesophageal junction cancer, gastrointestinal (gi) cancer, gastrointestinal (gi) cancer genomics, gastrointestinal (gi) stromal tumors, germinoma, gleason score, glottic cancer, head and neck cancer chemotherapy, hepatic artery infusion pump placement, hereditary kidney cancer, hereditary papillary renal cell cancer, histiocytoma, human t-cell lymphotropic virus type 1, human t-cell lymphotropic virus type 2, hypopharyngeal cancer chemotherapy, immunoassay for tumor antigen ca 125, immunoassay for tumor antigen ca 15-3 and ca 27-29, intestinal cancer, intravesical chemotherapy, kidney cancer, lacrimal gland cancer, large cell cancer of the lung, large cell neuroendocrine tumors, laryngeal cancer chemotherapy, liquid biopsy testing, liver cancer, liver cancer chemotherapy, liver cancer genomics, liver metastases, lung cancer, lung metastasis, malignant carcinoid tumor of colon, malignant granular cell tumor, malignant lung tumors, malignant spindle cell neoplasm, mediastinal lymphadenopathy, medullary cancer of thyroid, melanoma surgery, metastatic rib cancer, microsatellite instability, mouth cancer chemotherapy, multi-cancer early detection blood test, muscle invasive bladder cancer, nasopharyngeal cancer chemotherapy, neuroendocrine tumors |
| Video | https://www.youtube.com/watch?v=M3_EM4XHjqI |